Request for Covid-19 Impact Assessment of this Report

Healthcare

Global Solid Tumor Drugs Market Research Report 2015-2025

  • HEY3844292
  • 96 Pages
  • May 2020
  • Healthcare
Download Sample    Get Discount   
 
Summary

The global Solid Tumor Drugs market will reach xxx Million USD in 2020 with CAGR xx% 2020-2025. The objective of report is to define, segment, and project the market on the basis of product type, application, and region, and to describe the content about the factors influencing market dynamics, policy, economic, technology and market entry etc.

Based on products type, the report describes major products type share of regional market. Products mentioned as follows:

Small Molecules

Enzymes

Blood and Blood Components

Gene Therapy

Recombinant Proteins

Somatic Cells

Tissues

Vaccines

Leading vendors in the market are included based on profile, business performance etc. Vendors mentioned as follows:

AstraZeneca

Abbott Laboratories

Amgen Limited & Amgen Ireland Limited

Biogen

Baxter

Bristol-Myers Squibb Company

F. Hoffmann-La Roche

Eli Lilly and Company

Johnson & Johnson

GlaxoSmithKline

Celgene Corporation

Pfizer

Based on Application, the report describes major application share of regional market. Application mentioned as follows:

Oncology

Radiology

Neurology

Others

Based on region, the report describes major regions market by products and application. Regions mentioned as follows:

Asia-Pacific

North America

Europe

South America

Middle East & Africa

Table of Contents

1 Market Overview

1.1 Objectives of Research

1.1.1 Definition

Figure Solid Tumor Drugs Picture

1.1.2 Specifications

Table Product Specifications of Solid Tumor Drugs

1.2 Market Segment

1.2.1 by Type

Table Products Segment of Solid Tumor Drugs

Table Global Solid Tumor Drugs Market by Type, 2011-2022 (USD Million)

1.2.1.1 Small Molecules

Table Small Molecules Overview

1.2.1.2 Enzymes

Table Enzymes Overview

1.2.1.3 Blood and Blood Components

Table Blood and Blood Components Overview

1.2.1.4 Gene Therapy

Table Gene Therapy Overview

1.2.1.5 Recombinant Proteins

Table Recombinant Proteins Overview

1.2.1.6 Somatic Cells

Table Somatic Cells Overview

1.2.1.7 Tissues

Table Tissues Overview

1.2.1.8 Vaccines

Table Vaccines Overview

1.2.2 by Application

Table Application Segment of Solid Tumor Drugs

Table Global Solid Tumor Drugs Market by Application, 2011-2022 (USD Million)

1.2.2.1 Oncology

Table Oncology Overview

1.2.2.2 Radiology

Table Radiology Overview

1.2.2.3 Neurology

Table Neurology Overview

1.2.2.4 Others

Table Others Overview

1.2.3 by Regions

Table Global Solid Tumor Drugs Market by Region, 2011-2022 (USD Million)

2 Industry Chain

2.1 Industry Chain Structure

Figure Industry Chain Structure of Solid Tumor Drugs

2.2 Upstream

Table Cost of Solid Tumor Drugs

Figure Manufacturing Process of Solid Tumor Drugs

2.3 Market

2.3.1 SWOT

Figure SWOT of Solid Tumor Drugs

2.3.2 Dynamics

Table Market Dynamics

3 Environmental Analysis

3.1 Policy

Table Policy of Solid Tumor Drugs

3.2 Economic

Table GDP of Major Countries

3.3 Technology

Table Technology of Solid Tumor Drugs

3.4 Market Entry

Table Market Entry of Solid Tumor Drugs

4 Market Segmentation by Type

4.1 Market Size

4.1.1 Small Molecules Market, 2013-2018

Figure Small Molecules Market Size and Growth, 2015-2019 (USD Million)

Figure Small Molecules Market Size and Growth, 2015-2019 (in Volume)

Table Small Molecules CAGR by Revenue and Volume, 2015-2019

4.1.2 Enzymes Market, 2013-2018

Figure Enzymes Market Size and Growth, 2015-2019 (USD Million)

Figure Enzymes Market Size and Growth, 2015-2019 (in Volume)

Table Enzymes CAGR by Revenue and Volume, 2015-2019

4.1.3 Blood and Blood Components Market, 2013-2018

Figure Blood and Blood Components Market Size and Growth, 2015-2019 (USD Million)

Figure Blood and Blood Components Market Size and Growth, 2015-2019 (in Volume)

Table Blood and Blood Components CAGR by Revenue and Volume, 2015-2019

4.1.4 Gene Therapy Market, 2013-2018

Figure Gene Therapy Market Size and Growth, 2015-2019 (USD Million)

Figure Gene Therapy Market Size and Growth, 2015-2019 (in Volume)

Table Gene Therapy CAGR by Revenue and Volume, 2015-2019

4.1.5 Recombinant Proteins Market, 2013-2018

Figure Recombinant Proteins Market Size and Growth, 2015-2019 (USD Million)

Figure Recombinant Proteins Market Size and Growth, 2015-2019 (in Volume)

Table Recombinant Proteins CAGR by Revenue and Volume, 2015-2019

4.1.6 Somatic Cells Market, 2013-2018

Figure Somatic Cells Market Size and Growth, 2015-2019 (USD Million)

Figure Somatic Cells Market Size and Growth, 2015-2019 (in Volume)

Table Somatic Cells CAGR by Revenue and Volume, 2015-2019

4.1.7 Tissues Market, 2013-2018

Figure Tissues Market Size and Growth, 2015-2019 (USD Million)

Figure Tissues Market Size and Growth, 2015-2019 (in Volume)

Table Tissues CAGR by Revenue and Volume, 2015-2019

4.1.8 Vaccines Market, 2013-2018

Figure Vaccines Market Size and Growth, 2015-2019 (USD Million)

Figure Vaccines Market Size and Growth, 2015-2019 (in Volume)

Table Vaccines CAGR by Revenue and Volume, 2015-2019

4.2 Market Forecast

4.2.1 Small Molecules Market Forecast, 2020-2025

Figure Small Molecules Market Estimates and Forecasts, 2020-2025 (USD Million)

Figure Small Molecules Market Estimates and Forecasts, 2020-2025 (in Volume)

Table Small Molecules CAGR by Revenue and Volume, 2012-2024

4.2.2 Enzymes Market Forecast, 2020-2025

Figure Enzymes Market Estimates and Forecasts, 2020-2025 (USD Million)

Figure Enzymes Market Estimates and Forecasts, 2020-2025 (in Volume)

Table Enzymes CAGR by Revenue and Volume, 2012-2024

4.2.3 Blood and Blood Components Market Forecast, 2020-2025

Figure Blood and Blood Components Market Estimates and Forecasts, 2020-2025 (USD Million)

Figure Blood and Blood Components Market Estimates and Forecasts, 2020-2025 (in Volume)

Table Blood and Blood Components CAGR by Revenue and Volume, 2012-2024

4.2.4 Gene Therapy Market Forecast, 2020-2025

Figure Gene Therapy Market Estimates and Forecasts, 2020-2025 (USD Million)

Figure Gene Therapy Market Estimates and Forecasts, 2020-2025 (in Volume)

Table Gene Therapy CAGR by Revenue and Volume, 2012-2024

4.2.5 Recombinant Proteins Market Forecast, 2020-2025

Figure Recombinant Proteins Market Estimates and Forecasts, 2020-2025 (USD Million)

Figure Recombinant Proteins Market Estimates and Forecasts, 2020-2025 (in Volume)

Table Recombinant Proteins CAGR by Revenue and Volume, 2012-2024

4.2.6 Somatic Cells Market Forecast, 2020-2025

Figure Somatic Cells Market Estimates and Forecasts, 2020-2025 (USD Million)

Figure Somatic Cells Market Estimates and Forecasts, 2020-2025 (in Volume)

Table Somatic Cells CAGR by Revenue and Volume, 2012-2024

4.2.7 Tissues Market Forecast, 2020-2025

Figure Tissues Market Estimates and Forecasts, 2020-2025 (USD Million)

Figure Tissues Market Estimates and Forecasts, 2020-2025 (in Volume)

Table Tissues CAGR by Revenue and Volume, 2012-2024

4.2.8 Vaccines Market Forecast, 2020-2025

Figure Vaccines Market Estimates and Forecasts, 2020-2025 (USD Million)

Figure Vaccines Market Estimates and Forecasts, 2020-2025 (in Volume)

Table Vaccines CAGR by Revenue and Volume, 2012-2024

5 Market Segmentation by Application

5.1 Market Size

5.1.1 Oncology Market, 2013-2018

Figure Oncology Market Size and Growth, 2015-2019 (USD Million)

Figure Market Size and Growth, 2015-2019 (in Volume)

Table Oncology CAGR by Revenue and Volume, 2015-2019

5.1.2 Radiology Market, 2013-2018

Figure Radiology Market Size and Growth, 2015-2019 (USD Million)

Figure Market Size and Growth, 2015-2019 (in Volume)

Table Radiology CAGR by Revenue and Volume, 2015-2019

5.1.3 Neurology Market, 2013-2018

Figure Neurology Market Size and Growth, 2015-2019 (USD Million)

Figure Market Size and Growth, 2015-2019 (in Volume)

Table Neurology CAGR by Revenue and Volume, 2015-2019

5.1.4 Others Market, 2013-2018

Figure Others Market Size and Growth, 2015-2019 (USD Million)

Figure Market Size and Growth, 2015-2019 (in Volume)

Table Others CAGR by Revenue and Volume, 2015-2019

5.2 Market Forecast

5.2.1 Oncology Market Forecast, 2020-2025

Figure Oncology Market Estimates and Forecasts, 2020-2025 (USD Million)

Figure Oncology Market Estimates and Forecasts, 2020-2025 (in Volume)

Table Oncology CAGR by Revenue and Volume, 2020-2025

5.2.2 Radiology Market Forecast, 2020-2025

Figure Radiology Market Estimates and Forecasts, 2020-2025 (USD Million)

Figure Radiology Market Estimates and Forecasts, 2020-2025 (in Volume)

Table Radiology CAGR by Revenue and Volume, 2020-2025

5.2.3 Neurology Market Forecast, 2020-2025

Figure Neurology Market Estimates and Forecasts, 2020-2025 (USD Million)

Figure Neurology Market Estimates and Forecasts, 2020-2025 (in Volume)

Table Neurology CAGR by Revenue and Volume, 2020-2025

5.2.4 Others Market Forecast, 2020-2025

Figure Others Market Estimates and Forecasts, 2020-2025 (USD Million)

Figure Others Market Estimates and Forecasts, 2020-2025 (in Volume)

Table Others CAGR by Revenue and Volume, 2020-2025

6 Market Segmentation by Region

6.1 Market Size

6.1.1 Asia-Pacific

6.1.1.1 Asia-Pacific Market, 2015-2019

Figure Asia-Pacific Market Size and Growth, 2015-2019 (USD Million)

Figure Asia-Pacific Market Size and Growth, 2015-2019 (in Volume)

Table Asia-Pacific CAGR by Revenue and Volume, 2015-2019

6.1.1.2 Asia-Pacific Market by Type

Figure Asia-Pacific Market Size by Type

Figure Asia-Pacific Market Share by Type

6.1.1.3 Asia-Pacific Market by Application

Figure Asia-Pacific Market Size by Application

Figure Asia-Pacific Market Share by Application

6.1.2 North America

6.1.2.1 North America Market, 2015-2019

Figure North America Market Size and Growth, 2015-2019 (USD Million)

Figure North America Market Size and Growth, 2015-2019 (in Volume)

Table North America CAGR by Revenue and Volume, 2015-2019

6.1.2.2 North America Market by Type

Figure North America Market Size by Type

Figure North America Market Share by Type

6.1.2.3 North America Market by Application

Figure North America Market Size by Application

Figure North America Market Share by Application

6.1.3 Europe

6.1.3.1 Europe Market, 2015-2019

Figure Europe Market Size and Growth, 2015-2019 (USD Million)

Figure Europe Market Size and Growth, 2015-2019 (in Volume)

Table Europe CAGR by Revenue and Volume, 2015-2019

6.1.3.2 Europe Market by Type

Figure Europe Market Size by Type

Figure Europe Market Share by Type

6.1.3.3 Europe Market by Application

Figure Europe Market Size by Application

Figure Europe Market Share by Application

6.1.4 South America

6.1.4.1 South America Market, 2015-2019

Figure South America Market Size and Growth, 2015-2019 (USD Million)

Figure South America Market Size and Growth, 2015-2019 (in Volume)

Table South America CAGR by Revenue and Volume, 2015-2019

6.1.4.2 South America Market by Type

Figure South America Market Size by Type

Figure South America Market Share by Type

6.1.4.3 South America Market by Application

Figure South America Market Size by Application

Figure South America Market Share by Application

6.1.5 Middle East & Africa

6.1.5.1 Middle East & Africa Market, 2015-2019

Figure Middle East & Africa Market Size and Growth, 2015-2019 (USD Million)

Figure Middle East & Africa Market Size and Growth, 2015-2019 (in Volume)

Table Middle East & Africa CAGR by Revenue and Volume, 2015-2019

6.1.5.2 Middle East & Africa Market by Type

Figure Middle East & Africa Market Size by Type

Figure Middle East & Africa Market Share by Type

6.1.5.3 Middle East & Africa Market by Application

Figure Middle East & Africa Market Size by Application

Figure Middle East & Africa Market Share by Application

6.2 Market Forecast

6.2.1 Asia-Pacific Market Forecast, 2020-2025

Figure Asia-Pacific Market Estimates and Forecasts, 2020-2025 (USD Million)

Figure Asia-Pacific Market Estimates and Forecasts, 2020-2025 (in Volume)

Table Asia-Pacific CAGR by Revenue and Volume, 2020-2025

6.2.2 North America Market Forecast, 2020-2025

Figure North America Market Estimates and Forecasts, 2020-2025 (USD Million)

Figure North America Market Estimates and Forecasts, 2020-2025 (in Volume)

Table North America CAGR by Revenue and Volume, 2020-2025

6.2.3 Europe Market Forecast, 2020-2025

Figure Europe Market Estimates and Forecasts, 2020-2025 (USD Million)

Figure Europe Market Estimates and Forecasts, 2020-2025 (in Volume)

Table Europe CAGR by Revenue and Volume, 2020-2025

6.2.4 South America Market Forecast, 2020-2025

Figure South America Market Estimates and Forecasts, 2020-2025 (USD Million)

Figure South America Market Estimates and Forecasts, 2020-2025 (in Volume)

Table South America CAGR by Revenue and Volume, 2020-2025

6.2.5 Middle East & Africa Market Forecast, 2020-2025

Figure Middle East & Africa Market Estimates and Forecasts, 2020-2025 (USD Million)

Figure Middle East & Africa Market Estimates and Forecasts, 2020-2025 (in Volume)

Table Middle East & Africa CAGR by Revenue and Volume, 2020-2025

7 Market Competitive

7.1 Global Market by Vendors

Table Global Solid Tumor Drugs Market by Vendors, 2015-2019 (in Volume)

Table Global Solid Tumor Drugs Market Share by Vendors, 2015-2019 (USD Million)

Table Global Solid Tumor Drugs Market Share by Vendors, 2015-2019 (in Volume)

7.2 Market Concentration

Figure Solid Tumor Drugs Market Concentration by Region

7.3 Price & Factors

Table Price Factors List

7.4 Marketing Channel

Figure Marketing Channels Overview

8 Major Vendors

8.1 AstraZeneca

Table AstraZeneca Profile List

Table Microecological Modulator Operating Data of AstraZeneca (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

8.2 Abbott Laboratories

Table Abbott Laboratories Profile List

Table Microecological Modulator Operating Data of Abbott Laboratories (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

8.3 Amgen Limited & Amgen Ireland Limited

Table Amgen Limited & Amgen Ireland Limited Profile List

Table Microecological Modulator Operating Data of Amgen Limited & Amgen Ireland Limited (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

8.4 Biogen

Table Biogen Profile List

Table Microecological Modulator Operating Data of Biogen (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

8.5 Baxter

Table Baxter Profile List

Table Microecological Modulator Operating Data of Baxter (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

8.6 Bristol-Myers Squibb Company

Table Bristol-Myers Squibb Company Profile List

Table Microecological Modulator Operating Data of Bristol-Myers Squibb Company (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

8.7 F. Hoffmann-La Roche

Table F. Hoffmann-La Roche Profile List

Table Microecological Modulator Operating Data of F. Hoffmann-La Roche (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

8.8 Eli Lilly and Company

Table Eli Lilly and Company Profile List

Table Microecological Modulator Operating Data of Eli Lilly and Company (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

8.9 Johnson & Johnson

Table Johnson & Johnson Profile List

Table Microecological Modulator Operating Data of Johnson & Johnson (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

8.10 GlaxoSmithKline

Table GlaxoSmithKline Profile List

Table Microecological Modulator Operating Data of GlaxoSmithKline (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

8.11 Celgene Corporation

Table Celgene Corporation Profile List

Table Microecological Modulator Operating Data of Celgene Corporation (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

8.12 Pfizer

Table Pfizer Profile List

Table Microecological Modulator Operating Data of Pfizer (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

9 Conclusion

List of Table

Table Product Specifications of Solid Tumor Drugs

Table Products Segment of Solid Tumor Drugs

Table Global Solid Tumor Drugs Market by Type, 2011-2022 (USD Million)

Table Small Molecules Overview

Table Enzymes Overview

Table Blood and Blood Components Overview

Table Gene Therapy Overview

Table Recombinant Proteins Overview

Table Somatic Cells Overview

Table Tissues Overview

Table Vaccines Overview

Table Application Segment of Solid Tumor Drugs

Table Global Solid Tumor Drugs Market by Application, 2011-2022 (USD Million)

Table Oncology Overview

Table Radiology Overview

Table Neurology Overview

Table Others Overview

Table Global Solid Tumor Drugs Market by Region, 2011-2022 (USD Million)

Table Cost of Solid Tumor Drugs

Table Market Dynamics

Table Policy of Solid Tumor Drugs

Table GDP of Major Countries

Table Technology of Solid Tumor Drugs

Table Market Entry of Solid Tumor Drugs

Table Small Molecules CAGR by Revenue and Volume, 2015-2019

Table Enzymes CAGR by Revenue and Volume, 2015-2019

Table Blood and Blood Components CAGR by Revenue and Volume, 2015-2019

Table Gene Therapy CAGR by Revenue and Volume, 2015-2019

Table Recombinant Proteins CAGR by Revenue and Volume, 2015-2019

Table Somatic Cells CAGR by Revenue and Volume, 2015-2019

Table Tissues CAGR by Revenue and Volume, 2015-2019

Table Vaccines CAGR by Revenue and Volume, 2015-2019

Table Small Molecules CAGR by Revenue and Volume, 2012-2024

Table Enzymes CAGR by Revenue and Volume, 2012-2024

Table Blood and Blood Components CAGR by Revenue and Volume, 2012-2024

Table Gene Therapy CAGR by Revenue and Volume, 2012-2024

Table Recombinant Proteins CAGR by Revenue and Volume, 2012-2024

Table Somatic Cells CAGR by Revenue and Volume, 2012-2024

Table Tissues CAGR by Revenue and Volume, 2012-2024

Table Vaccines CAGR by Revenue and Volume, 2012-2024

Table Oncology CAGR by Revenue and Volume, 2015-2019

Table Radiology CAGR by Revenue and Volume, 2015-2019

Table Neurology CAGR by Revenue and Volume, 2015-2019

Table Others CAGR by Revenue and Volume, 2015-2019

Table Oncology CAGR by Revenue and Volume, 2020-2025

Table Radiology CAGR by Revenue and Volume, 2020-2025

Table Neurology CAGR by Revenue and Volume, 2020-2025

Table Others CAGR by Revenue and Volume, 2020-2025

Table Asia-Pacific CAGR by Revenue and Volume, 2015-2019

Table North America CAGR by Revenue and Volume, 2015-2019

Table Europe CAGR by Revenue and Volume, 2015-2019

Table South America CAGR by Revenue and Volume, 2015-2019

Table Middle East & Africa CAGR by Revenue and Volume, 2015-2019

Table Asia-Pacific CAGR by Revenue and Volume, 2020-2025

Table North America CAGR by Revenue and Volume, 2020-2025

Table Europe CAGR by Revenue and Volume, 2020-2025

Table South America CAGR by Revenue and Volume, 2020-2025

Table Middle East & Africa CAGR by Revenue and Volume, 2020-2025

Table Global Solid Tumor Drugs Market by Vendors, 2015-2019 (in Volume)

Table Global Solid Tumor Drugs Market Share by Vendors, 2015-2019 (USD Million)

Table Global Solid Tumor Drugs Market Share by Vendors, 2015-2019 (in Volume)

Table Price Factors List

Table AstraZeneca Profile List

Table Microecological Modulator Operating Data of AstraZeneca (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Abbott Laboratories Profile List

Table Microecological Modulator Operating Data of Abbott Laboratories (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Amgen Limited & Amgen Ireland Limited Profile List

Table Microecological Modulator Operating Data of Amgen Limited & Amgen Ireland Limited (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Biogen Profile List

Table Microecological Modulator Operating Data of Biogen (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Baxter Profile List

Table Microecological Modulator Operating Data of Baxter (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Bristol-Myers Squibb Company Profile List

Table Microecological Modulator Operating Data of Bristol-Myers Squibb Company (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table F. Hoffmann-La Roche Profile List

Table Microecological Modulator Operating Data of F. Hoffmann-La Roche (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Eli Lilly and Company Profile List

Table Microecological Modulator Operating Data of Eli Lilly and Company (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Johnson & Johnson Profile List

Table Microecological Modulator Operating Data of Johnson & Johnson (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table GlaxoSmithKline Profile List

Table Microecological Modulator Operating Data of GlaxoSmithKline (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Celgene Corporation Profile List

Table Microecological Modulator Operating Data of Celgene Corporation (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Pfizer Profile List

Table Microecological Modulator Operating Data of Pfizer (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

2020 World Blood Typing, Grouping and Infectious Disease NAT Screening Market in 68 Countries: Supplier Shares and Strategies, Volume and Sales Segment Forecasts for over 40 Tests, Technology and Instrumentation Review

This new 68-country report from LeadingMarketResearch.com is available by region, country, market segment, section, or individual test.

The report is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the global blood banking market during the next five years, and assist industry executives in developing effective business, new ...

  • Publish Date: March 2, 2020
  • $0
Hearing Aids Market in India 2011

Hearing aids in the form of analog units have been traditionally present and used in India. Digital hearing units are finding increased growth in acceptability owing to the changing perceptions and growing base of the target consumer group. The Indian market is largely dependent on imports from foreign countries; domestic players in the country are ramping up their manufacturing facilities. The gr...

  • Publish Date: March 10, 2011
  • $950
Cardiac Pacemaker Market in India 2011

The Indian medical devices market is largely dependent on imports from foreign countries. Although domestic players in the country are ramping up their manufacturing facilities, the foreign companies continue to enjoy a superior market share on account of their brand recognition, reliability, and technological superiority. The growing target base of consumers will boost sales and the market is exp...

  • Publish Date: July 18, 2011
  • $950